Vanda Pharma says James Kelly will become CFO

Vanda Pharmaceuticals Inc. said Friday that James Patrick Kelly will become its chief financial officer, treasurer, and secretary.

Kelly will join Vanda on Dec. 13. Since 2006, he has held a series of finance positions at MedImmune LLC, and before that he worked at Aetna Inc. and Biogen Idec Inc.

Vanda has not had a permanent CFO since January 2009, when Steven Shallcross stepped down as part of a series of job cuts. Stephanie Irish was the company's acting CFO from January 2009 until August 2010. Since then, the job has been handled by President and CEO Mihael Polymeropoulos.